Literature DB >> 1321771

Progressing toward a molecular description of colorectal cancer development.

E R Fearon1, P A Jones.   

Abstract

During the past decade, the powerful techniques of molecular biology and genetics have been applied to the study of human cancer. Colorectal tumors have proved to be an excellent system in which to search for and study the mutations involved in the development and progression of a common human cancer because of their natural history and several inherited syndromes that strongly predispose to colorectal cancer. A current view is that colorectal cancer results, at least in part, from the accumulation of multiple mutations in oncogenes and tumor suppressor genes in an affected cell. Although the genetic alterations often occur in a preferred sequence, the total accumulation of changes, rather than their order with respect to one another, appears to be a critical determinant of the biological properties of the tumor cell. Study of the inherited and somatic mutations in colorectal tumor cells may provide insights not only into the pathogenesis of cancer, but may also lead to future understanding of the mechanisms of the origin of mutations and the role of environmental and dietary factors in colorectal tumor development.

Entities:  

Mesh:

Year:  1992        PMID: 1321771     DOI: 10.1096/fasebj.6.10.1321771

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

Review 1.  Nutritional strategies in the prevention of colorectal cancer.

Authors:  J B Mason; Y i Kim
Journal:  Curr Gastroenterol Rep       Date:  1999-08

Review 2.  Molecular biology in colorectal cancer.

Authors:  Manuel Benito; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

3.  Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats.

Authors:  Y I Kim; R N Salomon; F Graeme-Cook; S W Choi; D E Smith; G E Dallal; J B Mason
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

4.  Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals.

Authors:  Xuehong Zhang; Stephanie A Smith-Warner; Andrew T Chan; Kana Wu; Donna Spiegelman; Charles S Fuchs; Walter C Willett; Edward L Giovannucci
Journal:  Am J Epidemiol       Date:  2011-06-14       Impact factor: 4.897

5.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 6.  Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors.

Authors:  M Streit; R Schmidt; R U Hilgenfeld; E Thiel; E D Kreuser
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

7.  Early genetic aberrations in patients with sporadic colorectal cancer.

Authors:  Brooke R Druliner; Xiaoyang Ruan; Hugues Sicotte; Daniel O'Brien; Hongfang Liu; Jean-Pierre A Kocher; Lisa Boardman
Journal:  Mol Carcinog       Date:  2017-10-18       Impact factor: 4.784

8.  Loss of heterozygosity: an independent prognostic factor of colorectal cancer.

Authors:  Shih-Ching Chang; Jen-Kou Lin; Tzu-Chen Lin; Wen-Yih Liang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

9.  Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer.

Authors:  A N Magewu; P A Jones
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.

Authors:  Audrey Ferrand; Mauro S Sandrin; Arthur Shulkes; Graham S Baldwin
Journal:  Biochim Biophys Acta       Date:  2009-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.